82228-09-9

Usage

Uses

Used in Organic Synthesis:
Methyl 2-O-Allyl-4,6-O-benzylidene-α-D-mannopyranoside is used as a key intermediate in organic synthesis for the preparation of various complex organic molecules. Its unique structure allows for selective reactions and transformations, making it a valuable building block in the synthesis of pharmaceuticals, agrochemicals, and other specialty chemicals.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, Methyl 2-O-Allyl-4,6-O-benzylidene-α-D-mannopyranoside is used as a starting material for the synthesis of novel drug candidates. Its unique structural features enable the development of new compounds with potential therapeutic applications, including the treatment of various diseases and disorders.
Used in Agrochemical Industry:
Methyl 2-O-Allyl-4,6-O-benzylidene-α-D-mannopyranoside is also utilized in the agrochemical industry for the synthesis of new pesticides and other crop protection agents. Its unique structure allows for the development of innovative compounds with improved efficacy and selectivity, contributing to more sustainable agricultural practices.
Used in Specialty Chemicals:
In the specialty chemicals sector, Methyl 2-O-Allyl-4,6-O-benzylidene-α-D-mannopyranoside is employed as a versatile building block for the synthesis of various specialty chemicals. Its unique structural features enable the development of new compounds with specific properties, such as improved solubility, stability, or reactivity, which can be tailored for specific applications in industries like materials science, coatings, and adhesives.

InChI:InChI=1/C17H22O6/c1-3-9-20-15-13(18)14-12(22-17(15)19-2)10-21-16(23-14)11-7-5-4-6-8-11/h3-8,12-18H,1,9-10H2,2H3

Upstream product

• 4148-58-7 (4aR,6S,7S,8R,8aS)-6-Methoxy-2-phenyl-hexahydro-pyrano[3,2-d][1,3]dioxine-7,8-diol 
• 556-56-9 allyl iodid 
• 3162-96-7 (4aS,6R,7S,8R,8aR)-6-Methoxy-2-phenyl-hexahydro-pyrano[3,2-d][1,3]dioxine-7,8-diol 

Downstream Products

• 81555-76-2 methyl 2-O-allyl-4,6-O-benzylidene-3-O-(2,3,4-tri-O-acetyl-α-D-lyxopyranosyl)-α-D-mannopyranoside 
• 108966-88-7 methyl 2-O-allyl-3-O-benzoyl-4,6-O-benzylidene-α-D-allopyranoside 
• 108966-93-4 methyl 6-aldehydo-2-O-allyl-3-O-benzoyl-4-deoxy-α-D-erythro-hex-4-enodialdo-1,5-pyranoside 
• 108966-94-5 methyl 2-O-allyl-3-O-benzoyl-4-deoxy-α-D-erythro-hex-4-enopyranoside 
• 108966-89-8 methyl 2-O-allyl-3-O-benzoyl-α-D-allopyranoside 
• 108966-92-3 methyl 2-O-allyl-3-O-benzoyl-4-O-methanesulfonyl-α-D-allopyranoside 
• 108966-95-6 Benzoic acid (2R,3S,4S)-3-allyloxy-6-methanesulfonyloxymethyl-2-methoxy-3,4-dihydro-2H-pyran-4-yl ester 
• 108966-90-1 methyl 2-O-allyl-3-O-benzoyl-6-O-trityl-α-D-allopyranoside 
• 108966-91-2 methyl 2-O-allyl-3-O-benzoyl-4-O-methanesulfonyl-6-O-trityl-α-D-allopyranoside 

Relevant academic research and scientific papers

SYNTHETIC STUDIES ON NOGALAMYCIN: STEREOSPECIFIC C-5 ALKYLATION OF A SUGAR DERIVATIVE VIA CLAISEN REARRANGEMENT AND A NEW ROUTE TO 1,1,4-TRIALKOXYBUTA-1,3-DIENES.

Claisen rearrangement of the 4-methoxybutadienylether of the allylic alcohol 13 which was made in 15 steps from D-glucose, afforded one major aldehyde 17 or 18 in good yield.All attempts to oxidize to an acid were unsuccessful.The model compound 24 and compound 13, were converted respectively to the α, β-unsaturated esters 25 and 26.Compound 25 was further transformed into 1,1,4-trialkoxybuta-1,3-diene 27 which was found unreactive towards quinones.